Similarly, sterol interventions such as stigmasterol have been shown to modulate specific Lactobacillus species, leading to increased IFN‐γ+CD8+T cells and tumor cell apoptosis, providing promising therapeutic avenues for HCC treatment [83]. This evidence concerns the gene CD8A and hepatocellular carcinoma.